As expected, the increased protein expression of HIF-1α, VEGF, pVEGFR2, and CD31 (PECAM-1), a specific endothelial cell marker, in tumor tissues determined by immunohistochemical staining or Western blotting assay was also greatly suppressed after AE-AS treatment (Fig. 6B). Here, VEGFA is linked to neoplasm.